首页> 外文会议>the European Peptide Symposium >EFFECTS OF HISTONE DEACETYLASE INHIBITORS BASED ON CHLAMYDOCIN TOWARD KK-A~y DIABETES MODEL MICE
【24h】

EFFECTS OF HISTONE DEACETYLASE INHIBITORS BASED ON CHLAMYDOCIN TOWARD KK-A~y DIABETES MODEL MICE

机译:基于衣原体对KK-A〜Y糖尿病模型小鼠的组蛋白脱乙酰酶抑制剂的影响

获取原文

摘要

Histone deacetylases (HDAC) have important roles in the regulation of the cell cycles by the cooperation with histone acetyl transferase. The HDACs involved in class-I and II have metalloprotease-related mechanism in its catalytic activity. These enzymes could be inhibited by small molecules bearing various zinc ligands such as hydroxamic acid and mercaptan. Based on the structure of chlamydocin, which has a cyclic tetrapeptide framework, cyclo(-L-Aoe-Aib-L-Phe-D-Pro-), where Aoe is (2S,9S)-2-amino-8-oxo-9,10-epoxydecanoyl, we have developed potent HDAC inhibitors.
机译:组蛋白脱乙酰酶(HDAC)通过与组蛋白乙酰转移酶的协作对细胞循环的调节具有重要作用。涉及II类和II类的HDAC在其催化活性中具有金属蛋白酶相关机制。这些酶可以被含有各种锌配体如羟肟酸和硫醇的小分子抑制。基于衣原体的结构,其具有环状四肽框架,Cyclo(-L-Aoe-AIB-L-PHE-pro-pro-pro-pro-pro-pro-pro-pro-pro-pro-pro-pro-pro-pro-pro-pro-pro-pro-pro-pro-oxo- 9,10-环氧二烷酰基,我们开发了有效的HDAC抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号